Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
Open Access
- 4 June 2014
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-11
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease that will affect quality of life and, working efficiency, and produce negative thoughts for patients. Current therapy of RA is treated with disease-modifying antirheumatic drugs (DMARDs). Although most of these treatment methods are effective, most patients still have a pleasant experience either due to poor efficacy or side effects or both. Interleukin-6 receptor (IL6R) is important in the pathogenesis of RA. In this study, we would like to detect the potential candidates which inhibit IL6R against RA from traditional Chinese medicine (TCM). We use TCM compounds from the TCM Database@Taiwan for virtually screening the potential IL6R inhibitors. The TCM candidate compound, calycosin, has potent binding affinity with IL6R protein. The molecular dynamics simulation was employed to validate the stability of interaction in the protein complex with calycosin. The analysis indicates that protein complex with calycosin is more stable. In addition, calycosin is known to be one of the components ofAngelica sinensis, which has been indicated to have an important role in the treatment of rheumatoid arthritis. Therefore, calycosin is a potential candidate as lead compounds for further study in drug development process with IL6R protein against rheumatoid arthritis.Keywords
Funding Information
- National Science Council (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- National Science Council (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- Asia University (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- Asia University (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- Asia University (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- China Medical University Hospital (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- China Medical University Hospital (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- China Medical University Hospital (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- Taiwan Department of Health Clinical Trial and Research Center of Excellence (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- Taiwan Department of Health Cancer Research Center of Excellence (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
- Ministry of Education, Taiwan (NSC102-2221-E-468-027, NSC102-2325-B039-001, ASIA100-CMU-2, ASIA101-CMU-2, 102-ASIA-07, DMR-103-058, DMR-103-001, DMR-103-096, DOH102-TD-B-111-004, MOHW103-TD-B-111-03)
This publication has 48 references indexed in Scilit:
- Drug Design for Neuropathic Pain Regulation from Traditional Chinese MedicineScientific Reports, 2013
- CAVER 3.0: A Tool for the Analysis of Transport Pathways in Dynamic Protein StructuresPLOS Computational Biology, 2012
- RETRACTED: Identification of Potent EGFR Inhibitors from TCM Database@TaiwanPLOS Computational Biology, 2011
- Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of InsulinPLOS ONE, 2010
- PONDR-FIT: A meta-predictor of intrinsically disordered amino acidsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- CHARMM: The biomolecular simulation programJournal of Computational Chemistry, 2009
- Environmental influences on risk for rheumatoid arthritisCurrent Opinion in Rheumatology, 2009
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular SimulationJournal of Chemical Theory and Computation, 2008
- TRAF1–C5as a Risk Locus for Rheumatoid Arthritis — A Genomewide StudyNew England Journal of Medicine, 2007
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994